Febuxostat is a xanthine oxidase inhibitor used to prevent gout attacks by lowering uric acid levels in the body. Gout is characterized by painful inflammation due to uric acid crystal deposition in the joints. By inhibiting uric acid production, Febuxostat effectively reduces inflammation and pain associated with gout flares. Its therapeutic role is crucial for patients managing chronic gout. In summary, Febuxostat is vital for preventing gout attacks.
Febuxostat inhibits the enzyme xanthine oxidase, thereby reducing the synthesis of uric acid in the body.
No published brands for this salt yet.